Danaher adds PNI mRNA capabilities to life sciences platform

The overall mRNA therapeutics and vaccines market is growing rapidly, accelerated by the development of COVID-19 mRNA vaccines

picture of

Breaking News

Evonik acquires German biomaterial developer

Evonik invested in JeNaCell through its own venture capital arm in 2015

Innovate UK funds biologics manufacturing consortium

This project aims to address challenges faced in the pharmaceutical industry by increasing flexibility and s ...

European Commission funds MetrioPharm COVID project

Project iMPact will receive funding under the HERA incubator

Remediating pharmaceutical quality systems

Much of our work involves helping companies remediate flawed quality systems. Find out the factors that can make your ...

CN Bio licenses gut modelling tool from MIT

The GuMi device was licensed by Professor Linda Griffith at MIT's Department of Biological Engineering and joint patent- ...

Lonza to supply prequalified cells for CN Bio OOC technology

Organ-on-a-chip technology has the potential to solve the issues presented by 2D cell cultures and animal models, the ...

Beximco Pharma: The Bangladeshi company connecting with the US

COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market

CPhI Awards 2021 open for entries

Held as part of CPhI Worldwide, which takes place 9-11 November 2021, the awards span the entire pharmaceutical supply ...

Catalent plans $100 million expansion of Italian facility

The initial phase of the expansion will see the installation of two 2,000 L single-use bioreactors within purpose-built ...

What does a pharmaceutical integrated services programme entail?

Here Kevin Duffield, Head of Client Services North America/United Kingdom discusses key attributes to look for in an ...

Addressing the need for cost-effective vaccine manufacturing

Process intensification and integrated continuous bioprocessing are two approaches that can be used to achieve cost- ...

Operational excellence: Delivering value to customers, patients and shareholders

Here Manoj Zalpuri, Gourav Bajpai and Shivam Saxena at Piramal Pharma Solutions discuss the benefits of a holistic ...

Orbit Discovery raises $7.6m in funding

The financing was led by Oxford Sciences Innovation, with participation from Borealis Ventures, Perivoli Innovations, ...

Charnwood Campus research facility recommissioned for CRO

Charnwood Molecular will be able to grow its teams and add drug discovery service lines at the modernised facility